Therefore, the paradox underlying the IL-10 blockade and whether it carries a beneficial or detrimental role in cancer treatment might be deciphered if we understood how exactly these cells react to IL-10 signalling through comprehensive genomic, epigenomic, and proteomic analysis. This evidence concerns the gene IL10 and cancer.